2 studies found for:    NCT00036270
Show Display Options
RSS Create an RSS feed from your search for:
NCT00036270
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane
Condition: Breast Neoplasms
Interventions: Drug: exemestane (Aromasin);   Drug: tamoxifen + exemestane
2 Completed Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: exemestane;   Drug: tamoxifen

Indicates status has not been verified in more than two years